Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals - 34 Year Stock Price History | VRTX

Historical daily share price chart and data for Vertex Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Vertex Pharmaceuticals as of January 17, 2025 is 422.00.
  • The all-time high Vertex Pharmaceuticals stock closing price was 516.74 on November 08, 2024.
  • The Vertex Pharmaceuticals 52-week high stock price is 519.88, which is 23.2% above the current share price.
  • The Vertex Pharmaceuticals 52-week low stock price is 377.85, which is 10.5% below the current share price.
  • The average Vertex Pharmaceuticals stock price for the last 52 weeks is 450.30.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Vertex Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 412.1455 405.7600 424.2600 402.4900 422.0000 4.79%
2024 450.5616 410.9100 516.7400 392.8100 402.7000 -1.03%
2023 339.1680 286.0200 410.6800 283.2300 406.8900 40.90%
2022 274.5959 222.5300 321.4800 221.4200 288.7800 31.50%
2021 204.4323 229.4300 241.3100 177.0100 219.6000 -7.08%
2020 251.5545 219.4500 303.1000 199.7700 236.3400 7.94%
2019 184.7418 164.0800 223.9100 163.7300 218.9500 32.13%
2018 167.4049 152.9100 192.7400 145.7200 165.7100 10.58%
2017 126.9038 74.8900 166.1100 74.8900 149.8600 103.42%
2016 88.1828 122.8900 123.4500 72.0200 73.6700 -41.45%
2015 123.7852 123.0700 141.4800 98.5000 125.8300 5.92%
2014 89.4849 73.8300 120.7800 62.4400 118.8000 59.89%
2013 68.0295 43.6500 88.5100 43.6500 74.3000 77.33%
2012 47.3818 32.2300 64.8500 32.2000 41.9000 26.17%
2011 44.0248 35.9900 58.0100 26.6000 33.2100 -5.20%
2010 36.8595 44.2400 44.2400 32.1500 35.0300 -18.25%
2009 33.6777 30.6900 43.5500 26.2300 42.8500 41.05%
2008 25.9329 23.1500 34.6800 14.5900 30.3800 30.78%
2007 31.3792 36.9000 40.5600 23.2300 23.2300 -37.92%
2006 35.8992 27.9000 45.1200 27.9000 37.4200 35.24%
2005 16.3817 10.2400 28.9200 8.8300 27.6700 161.78%
2004 10.0132 10.5000 11.9100 8.1700 10.5700 2.13%
2003 12.7675 16.3600 16.4000 8.0000 10.3500 -34.70%
2002 20.1402 24.5400 31.6100 12.9500 15.8500 -35.54%
2001 38.1837 63.1300 74.1900 16.5200 24.5900 -65.61%
2000 51.5357 18.7500 97.2500 16.7500 71.5000 308.57%
1999 13.1561 14.7200 17.5450 9.9400 17.5000 17.65%
1998 13.7489 16.6900 19.6250 7.6250 14.8750 -9.85%
1997 18.9003 19.1250 25.5650 12.8750 16.5000 -18.01%
1996 14.7045 13.0000 20.1250 11.0000 20.1250 51.89%
1995 8.4467 7.5000 13.2500 6.3750 13.2500 76.67%
1994 7.1147 9.0600 9.6250 5.2500 7.5000 -18.92%
1993 5.5591 5.1250 9.3750 3.3750 9.2500 89.74%
1992 5.3817 7.5000 8.6250 3.3750 4.8750 -33.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $108.677B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.268B 14.16
Gilead Sciences (GILD) United States $114.457B 20.73
Bristol Myers Squibb (BMY) United States $114.166B 48.11
CSL (CSLLY) Australia $83.439B 0.00
Regeneron Pharmaceuticals (REGN) United States $74.899B 17.05
GSK (GSK) United Kingdom $69.286B 8.02
Argenex SE (ARGX) Netherlands $38.667B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.764B 0.00
BioNTech SE (BNTX) Germany $26.834B 0.00
Illumina (ILMN) United States $21.676B 79.00
BeiGene (ONC) Cayman Islands $20.529B 0.00
Biogen (BIIB) United States $20.481B 8.80
Incyte (INCY) United States $13.857B 0.00
Genmab (GMAB) Denmark $13.765B 20.19
Genmab (GNMSF) Denmark $13.706B 16.44
Intra-Cellular Therapies (ITCI) United States $13.379B 0.00
Moderna (MRNA) United States $13.107B 0.00
Insmed (INSM) United States $12.972B 0.00
Bio-Techne Corp (TECH) United States $12.049B 46.52
BioMarin Pharmaceutical (BMRN) United States $11.727B 27.23
Sarepta Therapeutics (SRPT) United States $11.271B 101.72
Vaxcyte (PCVX) United States $10.632B 0.00
QIAGEN (QGEN) Netherlands $10.497B 21.60
Exelixis (EXEL) United States $10.338B 23.51
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Exact Sciences (EXAS) United States $9.576B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.547B 32.44
Repligen (RGEN) United States $8.993B 117.16
Roivant Sciences (ROIV) United Kingdom $8.117B 0.00
Ascendis Pharma (ASND) Denmark $7.776B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.326B 7.17
Zealand Pharma (ZLDPF) Denmark $7.065B 0.00
Blueprint Medicines (BPMC) United States $6.991B 0.00
Halozyme Therapeutics (HALO) United States $6.972B 15.75
Revolution Medicines (RVMD) United States $6.778B 0.00
Legend Biotech (LEGN) United States $5.965B 0.00
Telix Pharmaceuticals (TLX) Australia $5.617B 0.00
Cytokinetics (CYTK) United States $5.398B 0.00
Nuvalent (NUVL) United States $5.389B 0.00
Alkermes (ALKS) Ireland $4.768B 16.02
TG Therapeutics (TGTX) United States $4.600B 0.00
Guardant Health (GH) United States $4.530B 0.00
Axsome Therapeutics (AXSM) United States $4.455B 0.00
Krystal Biotech (KRYS) United States $4.268B 70.66
Verona Pharma American Depositary Share (VRNA) United Kingdom $4.215B 0.00
Scholar Rock Holding (SRRK) United States $4.038B 0.00
Alvotech (ALVO) Luxembourg $4.001B 0.00
Biohaven (BHVN) United States $3.801B 0.00
ADMA Biologics Inc (ADMA) United States $3.787B 40.05
Apellis Pharmaceuticals (APLS) United States $3.724B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.694B 0.00
Viking Therapeutics (VKTX) United States $3.638B 0.00
Arcellx (ACLX) United States $3.595B 0.00
Immunovant (IMVT) United States $3.502B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.459B 0.00
Avidity Biosciences (RNA) United States $3.450B 0.00
PTC Therapeutics (PTCT) United States $3.381B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.352B 0.00
Denali Therapeutics (DNLI) United States $3.156B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.937B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.924B 22.53
Vericel (VCEL) United States $2.916B 984.50
Zai Lab (ZLAB) China $2.851B 0.00
NovoCure (NVCR) Jersey $2.832B 0.00
Twist Bioscience (TWST) United States $2.823B 0.00
Amicus Therapeutics (FOLD) United States $2.812B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.800B 0.00
Merus (MRUS) Netherlands $2.701B 0.00
Kymera Therapeutics (KYMR) United States $2.630B 0.00
SpringWorks Therapeutics (SWTX) United States $2.576B 0.00
Edgewise Therapeutics (EWTX) United States $2.487B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.475B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.434B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.254B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.227B 18.51
CG Oncology (CGON) United States $2.211B 0.00
Protagonist Therapeutics (PTGX) United States $2.194B 13.84
Janux Therapeutics (JANX) United States $2.137B 0.00
Bavarian Nordic (BVNRY) Denmark $2.130B 13.05
Ligand Pharmaceuticals (LGND) United States $2.114B 52.78
Vera Therapeutics (VERA) United States $2.113B 0.00
ImmunityBio (IBRX) United States $2.049B 0.00
Mesoblast (MESO) Australia $1.984B 0.00
Beam Therapeutics (BEAM) United States $1.941B 0.00
IDEAYA Biosciences (IDYA) United States $1.917B 0.00
Certara (CERT) United States $1.877B 53.00
Agios Pharmaceuticals (AGIO) United States $1.849B 0.00
NeoGenomics (NEO) United States $1.824B 0.00
Iovance Biotherapeutics (IOVA) United States $1.801B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.778B 0.00
Akero Therapeutics (AKRO) United States $1.755B 0.00
Geron (GERN) United States $1.747B 0.00
Belite Bio (BLTE) United States $1.736B 0.00
Disc Medicine (IRON) United States $1.733B 0.00
WAVE Life Sciences (WVE) Singapore $1.676B 0.00
Apogee Therapeutics (APGE) United States $1.669B 0.00
MannKind (MNKD) United States $1.657B 42.93
Dynavax Technologies (DVAX) United States $1.637B 95.77
Fortrea Holdings (FTRE) United States $1.587B 50.54
Celldex Therapeutics (CLDX) United States $1.578B 0.00
Galapagos (GLPG) Belgium $1.566B 0.00
Structure Therapeutics (GPCR) United States $1.549B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.484B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.452B 0.00
Viridian Therapeutics (VRDN) United States $1.436B 0.00
Travere Therapeutics (TVTX) United States $1.434B 0.00
Vir Biotechnology (VIR) United States $1.392B 0.00
Nurix Therapeutics (NRIX) United States $1.356B 0.00
Novavax (NVAX) United States $1.346B 0.00
MiMedx (MDXG) United States $1.340B 35.08
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.339B 0.00
Praxis Precision Medicines (PRAX) United States $1.315B 0.00
Arcus Biosciences (RCUS) United States $1.284B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.265B 0.00
Arvinas (ARVN) United States $1.240B 0.00
ANI Pharmaceuticals (ANIP) United States $1.229B 16.75
Myriad Genetics (MYGN) United States $1.128B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.116B 0.00
Liquidia Technologies (LQDA) United States $1.091B 0.00
Spyre Therapeutics (SYRE) United States $1.061B 0.00
Pacira BioSciences (PCRX) United States $1.032B 9.72
Gyre Therapeutics (GYRE) United States $1.024B 0.00
Adaptive Biotechnologies (ADPT) United States $1.005B 0.00
Intellia Therapeutics (NTLA) United States $0.968B 0.00
Pharvaris (PHVS) Netherlands $0.960B 0.00
Zymeworks (ZYME) United States $0.956B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.940B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.921B 0.00
Oculis Holding AG (OCS) Switzerland $0.921B 0.00
CureVac (CVAC) Germany $0.918B 7.45
Cogent Biosciences (COGT) United States $0.887B 0.00
AbCellera Biologics (ABCL) Canada $0.877B 0.00
Nuvation Bio (NUVB) United States $0.845B 0.00
ArriVent BioPharma (AVBP) United States $0.823B 0.00
Tyra Biosciences (TYRA) United States $0.819B 0.00
Avid Bioservices (CDMO) United States $0.793B 0.00
Anavex Life Sciences (AVXL) United States $0.781B 0.00
Septerna (SEPN) United States $0.750B 0.00
Prothena (PRTA) Ireland $0.741B 0.00
CorMedix Inc (CRMD) United States $0.738B 0.00
Sana Biotechnology (SANA) United States $0.706B 0.00
Cytek Biosciences (CTKB) United States $0.703B 0.00
Castle Biosciences (CSTL) United States $0.699B 124.70
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.696B 0.00
Replimune (REPL) United States $0.694B 0.00
UniQure (QURE) Netherlands $0.685B 0.00
Pliant Therapeutics (PLRX) United States $0.682B 0.00
Pharming Group (PHAR) Netherlands $0.679B 0.00
Oric Pharmaceuticals (ORIC) United States $0.676B 0.00
89BIO (ETNB) United States $0.670B 0.00
Bicara Therapeutics (BCAX) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Immatics (IMTX) Germany $0.639B 0.00
Immunome (IMNM) United States $0.624B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.623B 0.00
LENZ Therapeutics (LENZ) United States $0.619B 0.00
Arbutus Biopharma (ABUS) United States $0.606B 0.00
Tectonic Therapeutic (TECX) United States $0.603B 0.00
Cullinan Therapeutics (CGEM) United States $0.597B 0.00
Dianthus Therapeutics (DNTH) United States $0.592B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.591B 0.00
Upstream Bio (UPB) United States $0.590B 0.00
GRAIL (GRAL) United States $0.585B 0.00
CARGO Therapeutics (CRGX) United States $0.570B 0.00
Kura Oncology (KURA) United States $0.565B 0.00
Humacyte (HUMA) United States $0.555B 0.00
Emergent Biosolutions (EBS) United States $0.535B 0.00
Opthea (OPT) Australia $0.531B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.525B 0.00
Erasca (ERAS) United States $0.523B 0.00
MaxCyte (MXCT) United States $0.522B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.511B 0.00
Stoke Therapeutics (STOK) United States $0.496B 0.00
Cartesian Therapeutics (RNAC) United States $0.490B 0.00
MeiraGTx Holdings (MGTX) United States $0.489B 0.00
AnaptysBio (ANAB) United States $0.482B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.476B 0.00
Entrada Therapeutics (TRDA) United States $0.475B 7.98
Rapport Therapeutics (RAPP) United States $0.464B 0.00
GH Research (GHRS) Ireland $0.462B 0.00
Mineralys Therapeutics (MLYS) United States $0.460B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.455B 0.00
ChromaDex (CDXC) United States $0.454B 594.00
Annexon (ANNX) United States $0.448B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.444B 0.00
Keros Therapeutics (KROS) United States $0.440B 0.00
Sage Therapeutics (SAGE) United States $0.433B 0.00
Alpha Teknova (TKNO) United States $0.430B 0.00
Astria Therapeutics (ATXS) United States $0.423B 0.00
PureTech Health (PRTC) United States $0.419B 0.00
Kamada (KMDA) Israel $0.412B 25.57
Codexis (CDXS) United States $0.407B 0.00
Celcuity (CELC) United States $0.406B 0.00
Abivax SA (ABVX) France $0.390B 0.00
Aura Biosciences (AURA) United States $0.388B 0.00
Revance Therapeutics (RVNC) United States $0.384B 0.00
Allogene Therapeutics (ALLO) United States $0.382B 0.00
Prime Medicine (PRME) United States $0.379B 0.00
Kodiak Sciences (KOD) United States $0.377B 0.00
Terns Pharmaceuticals (TERN) United States $0.376B 0.00
Eton Pharmaceuticals (ETON) United States $0.375B 0.00
Northwest Biotherapeutics (NWBO) United States $0.374B 0.00
REGENXBIO (RGNX) United States $0.365B 0.00
Alumis (ALMS) United States $0.362B 0.00
Compass Therapeutics (CMPX) United States $0.358B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.347B 0.00
Absci (ABSI) United States $0.333B 0.00
Neumora Therapeutics (NMRA) United States $0.331B 0.00
MBX Biosciences (MBX) United States $0.331B 0.00
Zenas BioPharma (ZBIO) United States $0.328B 0.00
Precigen (PGEN) United States $0.325B 0.00
Olema Pharmaceuticals (OLMA) United States $0.324B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.322B 0.00
Contineum Therapeutics (CTNM) United States $0.321B 0.00
Chimerix (CMRX) United States $0.319B 0.00
EnGene Holdings (ENGN) Canada $0.316B 0.00
XOMA Royalty (XOMA) United States $0.315B 0.00
Tango Therapeutics (TNGX) United States $0.306B 0.00
ATyr Pharma (ATYR) United States $0.303B 0.00
ITeos Therapeutics (ITOS) United States $0.292B 0.00
Trevi Therapeutics (TRVI) United States $0.289B 0.00
Design Therapeutics (DSGN) United States $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.285B 0.00
Rezolute (RZLT) United States $0.282B 0.00
Prima BioMed (IMMP) Australia $0.281B 0.00
C4 Therapeutics (CCCC) United States $0.278B 0.00
Voyager Therapeutics (VYGR) United States $0.277B 7.14
Y-mAbs Therapeutics (YMAB) United States $0.276B 0.00
AC Immune (ACIU) Switzerland $0.265B 0.00
BioStem Technologies (BSEM) $0.265B 23.38
Third Harmonic Bio (THRD) United States $0.261B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.254B 0.00
Neurogene (NGNE) United States $0.247B 0.00
DiaMedica Therapeutics (DMAC) United States $0.244B 0.00
Nautilus Biotechnology (NAUT) United States $0.242B 0.00
Urogen Pharma (URGN) United States $0.241B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.240B 0.00
Lifecore Biomedical (LFCR) United States $0.240B 0.00
Foghorn Therapeutics (FHTX) United States $0.240B 0.00
Benitec Biopharma (BNTC) United States $0.239B 0.00
Verastem (VSTM) United States $0.237B 0.00
Anika Therapeutics (ANIK) United States $0.235B 0.00
Amarin (AMRN) Ireland $0.229B 0.00
Sangamo Therapeutics (SGMO) United States $0.227B 0.00
Abeona Therapeutics (ABEO) United States $0.227B 0.00
Molecular Partners AG (MOLN) Switzerland $0.224B 0.00
Semper Paratus Acquisition (TVGN) United States $0.224B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.223B 0.00
Gossamer Bio (GOSS) United States $0.218B 0.00
Candel Therapeutics (CADL) United States $0.216B 0.00
Fulcrum Therapeutics (FULC) United States $0.214B 0.00
Ocugen (OCGN) United States $0.207B 0.00
TuHURA Biosciences (HURA) United States $0.203B 0.00
Compugen (CGEN) Israel $0.201B 112.50
Orchestra BioMed Holdings (OBIO) United States $0.201B 0.00
ACELYRIN, INC (SLRN) United States $0.200B 0.00
Inhibrx Biosciences (INBX) United States $0.195B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.194B 0.00
BioAge Labs (BIOA) United States $0.184B 0.00
Adocia (ADOCY) France $0.183B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.177B 0.00
Cardiff Oncology (CRDF) United States $0.176B 0.00
Nkarta (NKTX) United States $0.174B 0.00
Monopar Therapeutics (MNPR) United States $0.174B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.170B 0.00
Greenwich LifeSciences (GLSI) United States $0.169B 0.00
Actuate Therapeutics (ACTU) United States $0.168B 0.00
Alector (ALEC) United States $0.167B 0.00
Sutro Biopharma (STRO) United States $0.166B 0.00
ScPharmaceuticals (SCPH) United States $0.164B 0.00
Bright Minds Biosciences (DRUG) United States $0.163B 0.00
Coherus BioSciences (CHRS) United States $0.160B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.160B 0.00
Artiva Biotherapeutics (ARTV) United States $0.159B 0.00
Checkpoint Therapeutics (CKPT) United States $0.155B 0.00
Cidara Therapeutics (CDTX) United States $0.153B 0.00
Adherex Technologies (FENC) United States $0.153B 0.00
InflaRx (IFRX) Germany $0.150B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.148B 0.00
Puma Biotechnology (PBYI) United States $0.146B 6.19
Fate Therapeutics (FATE) United States $0.145B 0.00
Biomea Fusion (BMEA) United States $0.144B 0.00
Kyverna Therapeutics (KYTX) United States $0.144B 0.00
INmune Bio (INMB) United States $0.143B 0.00
Ventyx Biosciences (VTYX) United States $0.143B 0.00
Innate Pharma S.A (IPHA) France $0.142B 0.00
Akoya Biosciences (AKYA) United States $0.140B 0.00
Caribou Biosciences (CRBU) United States $0.139B 0.00
Instil Bio (TIL) United States $0.137B 0.00
Seer (SEER) United States $0.135B 0.00
Sagimet Biosciences (SGMT) United States $0.135B 0.00
2seventy Bio (TSVT) United States $0.135B 0.00
Cabaletta Bio (CABA) United States $0.134B 0.00
Climb Bio (CLYM) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.131B 0.00
Solid Biosciences (SLDB) United States $0.131B 0.00
TScan Therapeutics (TCRX) United States $0.128B 0.00
Alto Neuroscience (ANRO) United States $0.125B 0.00
Black Diamond Therapeutics (BDTX) United States $0.124B 0.00
Aligos Therapeutics (ALGS) United States $0.123B 0.00
XBiotech (XBIT) United States $0.116B 0.00
Zura Bio (ZURA) United States $0.116B 0.00
Inventiva S.A (IVA) France $0.113B 0.00
Renovaro (RENB) United States $0.112B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
Elutia (ELUT) United States $0.111B 0.00
Nuvectis Pharma (NVCT) United States $0.106B 0.00
TELA Bio (TELA) United States $0.106B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
IGM Biosciences (IGMS) United States $0.105B 0.00
Editas Medicine (EDIT) United States $0.101B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.098B 0.00
BioHarvest Sciences (BHST) Canada $0.096B 0.00
Alpha Cognition (ACOG) Canada $0.095B 0.00
HilleVax (HLVX) United States $0.095B 0.00
23andMe Holding (ME) United States $0.094B 0.00
CAMP4 Therapeutics (CAMP) United States $0.093B 0.00
DBV Technologies S.A (DBVT) France $0.092B 0.00
ALX Oncology Holdings (ALXO) United States $0.092B 0.00
Vor Biopharma (VOR) $0.091B 0.00
Citius Oncology (CTOR) United States $0.091B 0.00
Adverum Biotechnologies (ADVM) United States $0.090B 0.00
Coya Therapeutics (COYA) United States $0.090B 0.00
MediciNova (MNOV) United States $0.090B 0.00
Inozyme Pharma (INZY) United States $0.087B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.087B 0.00
I-Mab (IMAB) China $0.087B 0.00
X4 Pharmaceuticals (XFOR) United States $0.087B 0.00
Scilex Holding (SCLX) United States $0.086B 0.00
Immunic (IMUX) United States $0.086B 0.00
Genelux (GNLX) United States $0.085B 0.00
Entera Bio (ENTX) Israel $0.084B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Jasper Therapeutics (JSPR) United States $0.083B 0.00
Cellectis S.A (CLLS) France $0.082B 0.00
Agenus (AGEN) United States $0.082B 0.00
Adagene (ADAG) China $0.081B 0.00
VistaGen Therapeutics (VTGN) United States $0.081B 0.00
Bluebird Bio (BLUE) United States $0.081B 0.00
Skye Bioscience (SKYE) United States $0.081B 0.00
Theratechnologies (THTX) Canada $0.079B 0.00
Vigil Neuroscience (VIGL) United States $0.079B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Allakos (ALLK) United States $0.076B 0.00
Mersana Therapeutics (MRSN) United States $0.076B 0.00
Applied Therapeutics (APLT) United States $0.076B 0.00
Adlai Nortye (ANL) Cayman Islands $0.076B 0.00
Rani Therapeutics Holdings (RANI) United States $0.075B 0.00
PepGen (PEPG) United States $0.075B 0.00
Adicet Bio (ACET) United States $0.075B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.075B 0.00
Aadi Bioscience (AADI) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
Ikena Oncology (IKNA) United States $0.072B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Annovis Bio (ANVS) United States $0.069B 0.00
BGM Group (BGM) China $0.069B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
Elicio Therapeutics (ELTX) United States $0.067B 0.00
BeyondSpring (BYSI) United States $0.067B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
Abpro Holdings (ABP) United States $0.067B 0.00
Invizyne Technologies (IZTC) United States $0.066B 0.00
CytomX Therapeutics (CTMX) United States $0.066B 4.94
Generation Bio (GBIO) United States $0.063B 0.00
Oncolytics Biotech (ONCY) Canada $0.063B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Immuneering (IMRX) United States $0.063B 0.00
FibroBiologics (FBLG) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.059B 0.00
Connect Biopharma Holdings (CNTB) United States $0.058B 0.00
Boundless Bio (BOLD) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
IO Biotech (IOBT) Denmark $0.055B 0.00
Repare Therapeutics (RPTX) Canada $0.054B 0.00
Inovio Pharmaceuticals (INO) United States $0.054B 0.00
PDS Biotechnology (PDSB) United States $0.054B 0.00
Earth Science Tech (ETST) United States $0.054B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
Ovid Therapeutics (OVID) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Fortress Biotech (FBIO) United States $0.052B 0.00
Celularity (CELU) United States $0.051B 0.00
Xilio Therapeutics (XLO) United States $0.050B 0.00
Spero Therapeutics (SPRO) United States $0.050B 13.00
Invivyd (IVVD) United States $0.049B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.047B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Aileron Therapeutics (RNTX) United States $0.043B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
Elevation Oncology (ELEV) United States $0.042B 0.00
Rapt Therapeutics (RAPT) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.042B 0.00
Intensity Therapeutics (INTS) United States $0.042B 0.00
CalciMedica (CALC) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.041B 0.00
Clene (CLNN) United States $0.040B 0.00
Q32 Bio (QTTB) United States $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Precision BioSciences (DTIL) United States $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
Atara Biotherapeutics (ATRA) United States $0.038B 0.00
Grace Therapeutics (GRCE) Canada $0.037B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Rallybio (RLYB) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.036B 0.00
Opus Genetics (IRD) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
MiNK Therapeutics (INKT) United States $0.035B 0.00
Enzo Biochem (ENZ) United States $0.034B 0.00
KALA BIO (KALA) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
Medicus Pharma (MDCX) Canada $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.031B 0.00
Cadrenal Therapeutics (CVKD) United States $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.031B 0.00
Omega Therapeutics (OMGA) United States $0.030B 0.00
Beyond Air (XAIR) United States $0.030B 0.00
UNITY Biotechnology (UBX) United States $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Cognition Therapeutics (CGTX) United States $0.028B 0.00
Curis (CRIS) United States $0.028B 0.00
Exicure (XCUR) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
LakeShore Biopharma (LSB) China $0.025B 0.00
Longeveron (LGVN) United States $0.025B 0.00
Prana Biotechnology (ATHE) Australia $0.025B 0.00
Pluri (PLUR) Israel $0.024B 0.00
BioAtla (BCAB) United States $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
Cyclo Therapeutics (CYTH) United States $0.023B 0.00
Equillium (EQ) United States $0.023B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.022B 0.00
IN8bio (INAB) United States $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.021B 0.00
Cara Therapeutics (CARA) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
Aprea Therapeutics (APRE) United States $0.021B 0.00
Gelteq (GELS) Australia $0.021B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
OnKure Therapeutics (OKUR) United States $0.019B 0.00
Ocean Biomedical (OCEA) United States $0.019B 0.00
Affimed (AFMD) Germany $0.019B 0.00
Palvella Therapeutics (PVLA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
BioXcel Therapeutics (BTAI) United States $0.017B 0.00
MetaVia (MTVA) United States $0.017B 0.00
BRIACELL THERAP (BCTX) Canada $0.017B 0.00
NKGen Biotech (NKGN) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Spruce Biosciences (SPRB) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
CervoMed (CRVO) United States $0.013B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Carmell (CTCX) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
BioAffinity Technologies (BIAF) United States $0.011B 0.00
Apollomics (APLM) United States $0.010B 0.00
Hoth Therapeutics (HOTH) United States $0.010B 0.00
Turnstone Biologics (TSBX) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
Silo Pharma (SILO) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.005B 0.00
Vincerx Pharma (VINC) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Evaxion Biotech (EVAX) Denmark $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NAYA Biosciences (NAYA) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00